Table 5.
OR | 95% (CI) | P | ||
---|---|---|---|---|
Lower limit | Upper limit | |||
VD grade | 0.019 | |||
VD grade 2 | 0.961 | 0.676 | 1.366 | 0.823 |
VD grade 3 | 0.621 | 0.421 | 0.915 | 0.016 |
Admission time | 0.745 | 0.558 | 0.995 | 0.046 |
TG | 0.751 | 0.657 | 0.858 | <0.001 |
HDL‐C | 0.282 | 0.184 | 0.433 | <0.001 |
DN | 2.376 | 1.762 | 3.204 | <0.001 |
DR | 1.959 | 1.457 | 2.636 | <0.001 |
DPN | 13.334 | 7.643 | 23.262 | <0.001 |
PAD | 4.354 | 3.208 | 5.909 | <0.001 |
DAN | 4.676 | 3.442 | 6.351 | <0.001 |
Smoking history | 1.575 | 1.169 | 2.121 | 0.003 |
Did not enter the equation: age, sex, BMI, LDL, CHOL; DF, diabetic foot; VD grade: vitamin D deficiency and it was regarded as the control group; VD grade 2: vitamin D insufficiency; VD grade 3: vitamin D normal; admission time: season of admission; TG, triglycerides; HDL‐C, high‐density lipoprotein cholesterol; DN, diabetic nephropathy; DR, diabetic retinopathy; DPN, diabetic peripheral neuropathy; PAD, peripheral arterial disease; DAN, diabetic autonomic neuropathy.